CAS 2229039-45-4

ZL0420

CAS: 2229039-45-4

Formel: C₁₆H₁₆N₄O₂

Reinheit: 99%

Farbe und Form: Solid

Molekulargewicht: 296.3238

Ref: IN-DA01FSKO

6-((2-Amino-4-Hydroxy-5-Methylphenyl)Diazenyl)-3,4-Dihydroquinolin-2(1H)-One

CAS: 2229039-45-4

6-((2-Amino-4-Hydroxy-5-Methylphenyl)Diazenyl)-3,4-Dihydroquinolin-2(1H)-One

Reinheit: 99%

Molekulargewicht: 296.32g/mol

Ref: 54-OR1023122

ZL0420

CAS: 2229039-45-4

ZL0420

Reinheit: ≥95%

Molekulargewicht: 296.32g/mol

Ref: 54-BUP10029

ZL0420

CAS: 2229039-45-4

ZL0420: Potent, selective BRD4 inhibitor, IC50 27 nM BD1 & 32 nM BD2.

Formel: C₁₆H₁₆N₄O₂

Reinheit: 99.38%

Farbe und Form: Solid

Molekulargewicht: 296.32

Ref: TM-T6828

ZL0420

CAS: 2229039-45-4

ZL0420 is a histone lysine protein inhibitor. It is a small molecule that binds to the bromodomain and inhibits the interaction of histone H3 with the dextran sulfate, preventing transcriptional activation. ZL0420 has been shown to inhibit cancer cell growth in vitro and in vivo. It also inhibits inflammatory gene expression in cultured human colon cells and reduces inflammation in mice with bowel disease. ZL0420 is currently being studied for its potential to treat inflammatory bowel disease and other conditions such as cancer, which are characterized by aberrant epigenetic changes.

Formel: C₁₆H₁₆N₄O₂

Reinheit: Min. 95%

Molekulargewicht: 296.32 g/mol

Ref: 3D-EPD03945